Titan Medical Inc (TMD.TO)
0.05
0.00 (0.00%)
CAD |
TSX |
May 17, 16:00
Titan Medical Revenue (Quarterly): 0.6806M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6806M |
| September 30, 2023 | 0.6039M |
| June 30, 2023 | 22.42M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | 12.60M |
| September 30, 2021 | |
| June 30, 2021 | 12.33M |
| March 31, 2021 | 0.0633M |
| December 31, 2020 | 13.03M |
| September 30, 2020 | |
| June 30, 2020 | 13.86M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0633M
Minimum
Mar 2021
22.42M
Maximum
Jun 2023
9.448M
Average
12.46M
Median
Revenue (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.414M |
| Total Expenses (Quarterly) | 0.0898M |
| EPS Diluted (Quarterly) | -0.0408 |
| Enterprise Value | -4.301M |
| Profit Margin (Quarterly) | -648.6% |
| Earnings Yield | 107.6% |
| Operating Earnings Yield | 195.7% |
| Normalized Earnings Yield | 191.41 |